Hatteras Venture Partners IV SBIC LP 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 4:16 pm Sale | 2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX | Hatteras Venture Partners IV SBIC LP | 1,756,462 4.600% | -259,926 (-12.89%) | Filing |
| 2020-02-11 4:20 pm Sale | 2019-12-31 | 13G | G1 Therapeutics, Inc. GTHX | Hatteras Venture Partners IV SBIC LP | 2,016,388 5.400% | -640,869 (-24.12%) | Filing |